23
Views
5
CrossRef citations to date
0
Altmetric
Research Article

An immunohistochemical method that differentiates Cryptococcus neoformans varieties and serotypes in formalin-fixed paraffin-embedded tissues

, , , , , , , & show all
Pages 523-533 | Published online: 09 Jul 2009

References

  • Kwon-Chung KJ, Bennett JE. Epidemiologic differences be-tween the two varieties of Cry ptococcus neoformans. Am J Epidemiol 1984; 120:123–130.
  • Kwon-Chung KJ, Bennett JE. High prevalence of Cryptococcus neoformans var. gattii in tropical and subtropical regions. Zentralbl Bakteriol Mikrobiol Hyg [A] 1984; 257:213–218.
  • Levitz SM. The ecology of Cryptococcus neoformans and the epidemiology of cryptococcosis. Rev Infect Dis 1991; 13: 1163–1169.
  • Mitchell TG, Perfect JR. Cryptococcosis in the era of AIDS: 100 years after the discovery of Cryptococcus neoformans. Gun Microbiol Rev 1995; 8: 515–548.
  • Malik R, Wigney DI, Martin P, Love DN, Muir DB. Veterinary aspects of cryptococcosis. Milan, 1993. 2nd International Conference on Cryptococcus and Cryptococcosis: In: Programs and Abstracts, p. 29.
  • Kwon-Chung KJ, Bennett JE, Rhodes JC. Taxonomic studies on Filobasidiella species and their anamorphs. Antonie van Leeuwenhoek 1982; 48: 25–38.
  • Vanbreuseghem R, Takashio M. An atypical strain of Crypto-coccus neoformans (San Felice) Vuillemin 1894. II. Cryptococ-cus neoformans var. gattii var. nov. Ann Soc Be1g Med Trop 1970; 50: 695–702.
  • Wilson DE, Bennett JE, Bailey JW. Serologic grouping of Cryptococcus neoformans. Proc Soc Exp Biol Med 1968; 127: 820–823.
  • Emmons CW. Saprophytic sources of Cryptococcus neoformans associated with the pigeon (Columbia livia). Am J Hyg 1955; 62: 227–232.
  • Pfeiffer TJ, Ellis DH. Serotypes of Australian environmental and clinical isolates of Cryptococcus neoformans. J Med Vet Mycol 1993; 31: 401–404.
  • Bennett JE, Kwon-Chung KJ, Howard DH. Epidemiologic differences among serotypes of Cryptococcus neoformans. Am J Epidemiol 1977; 105: 582–586.
  • Dromer F, Mathoulin S, Dupont B, Laporte A. Epidemiology of cryptococcosis in France: a 9-year survey (1985-1993). French Cryptococcosis Study Group. Clin Infect Dis 1996; 23: 82–90.
  • Franzot SP, Salkin IF, Casadevall A. Cryptococcus neoformans var. grubii: separate varietal status for Cryptococcus neoformans serotype A isolates. J Clin Microbiol 1999; 37: 838–840.
  • Kwon-Chung KJ, Varma A, Howard DH. Ecology of Crypto-coccus neoformans and prevalence of its two varieties in AIDS and non-AIDS associated cryptococcosis. In: Vanden Bossche H, Mackenzie DWR, Cauwenbergh G, et al., eds. Mycoses in AIDS Patients. New York: Plenum Press, 1990: 103–113.
  • Ellis DH. Cryptococcus neoformans var. gattii in Australia. J Clin Microbiol 1987; 25: 430–431.
  • Currie B, Vigus T, Leach G, Dwyer B. Cryptococcus neofor-mans var. gattii [letter; comment]. Lancet 1990; 336: 1442.
  • Ellis DH, Pfeiffer TJ. Natural habitat of Cryptococcus neofor-mans var. gattii. J Clin Microbiol 1990; 28: 1642–1644.
  • Ellis DH, Pfeiffer TJ. Ecology, life cycle, and infectious propagule of Cryptococcus neoformans. Lancet 1990; 336: 923–925.
  • Ellis D, Pfeiffer T. The ecology of Cryptococcus neoformans. Eur J Epidemiol 1992; 8: 321–325.
  • Pfeiffer TJ, Ellis DH. Environmental isolation of Cryptococcus neoformans var. gattii from Eucalyptus tereticornis. J Med Vet Mycol 1992; 30: 407–408.
  • Pfeiffer T, Ellis D. Environmental isolation of Cryptococcus neoformans var. gattii from California. J Infect Dis 1991; 163: 929–930.
  • Halliday CL, Bui T, Krockenberger M, Malik R, Ellis DH, Carter DA. Presence of alpha and a mating types in environ-mental and clinical collections of Cryptococcus neoformans var. gattii strains from Australia. J Clin Microbiol 1999; 37: 2920–2926.
  • Chakrabarti A, Jatana M, Kumar P, Chatha L, Kaushal A, Padhye AA. Isolation of Cryptococcus neoformans var. gattii from Eucalyptus camaldulensis in India. J Clin Microbiol 1997; 35: 3340–3342.
  • Speed B, Dunt D. Clinical and host differences between infections with the two varieties of Cryptococcus neoformans. Clin Infect Dis 1995; 21: 28–34; discussion 35-36.
  • Mitchell DH, Sorrell TC, Allworth AM, et aL Cryptococcal disease of the CNS in immunocompetent hosts: influence of cryptococcal variety on clinical manifestations and outcome. Clin Infect Dis 1995; 20: 611–616.
  • Walker C, Malik R, Canfield PJ. Analysis of leucocytes and lymphocyte subsets in cats with naturally occurring cryptococ-cosis but differing feline immunodefriency virus status. Aust Vet J 1995; 72: 93–97.
  • Malik R, Speed BR, Kaldor J, et aL Serum antibody response to Cryptococcus neoformans in cats, dogs and koalas with and without active infection. Med Mycol 1999; 37: 43–51.
  • Mancianti F, Giannelli C, Bendinelli M, Poli A. Mycological findings in feline immunodeficiency virus-infected cats. J Med Vet Mycol 1992; 30: 257–259.
  • Cabanes FJ, Abarca ML, Bonavia R, Bragulat MR, Castella G, Ferrer L. Cryptococcosis in a cat seropositive for feline immunodefriency virus. Mycoses 1995; 38: 131–133.
  • Jacobs GJ, Medleau L, Calvert C, Brown J. Cryptococcal infection in cats: factors influencing treatment outcome, and results of sequential serum antigen titers in 35 cats. J Vet Intern Med 1997; 11: 1–4.
  • Flatland B, Greene RT, Lappin MR. Clinical and serologic evaluation of cats with cryptococcosis. J Am Vet Med Assoc 1996; 209: 1110–1113.
  • Spencer A, Ley C, Canfield P, Martin P, Perry R. Meningoen-cephalitis in a koala (Phascolaraus cinereus) due to Crypto-coccus neoformans var. gattii infection. J Zoo Wildl Med 1993; 24: 519–522.
  • Casadevall A, Perfect JR. Cryptococcus neoformans. Washing-ton, D.C.: ASM Press, 1998.
  • Fisher D, Burrow J, Lo D, Currie B. Cryptococcus neoformans in tropical northern Australia: predominantly variant gattii with good outcomes. Aust N Z J Med 1993; 23: 678–682.
  • Dimech WJ. Diagnosis, identification and epidemiology of Cryptococcus neoformans infection. Aust J Med Lab Sci 1991; 1/ 13–21.
  • Kwon-Chung KJ, Polacheck I, Bennett JE. Improved diagnostic medium for separation of Cryptococcus neoformans var. neofor-mans (serotypes A and D) and Cryptococcus neoformans var. gattii (serotypes B and C). J Clin Microbiol 1982; 15: 535–537.
  • Belay T, Chemiak R, Kozel TR, Casadevall A. Reactivity patterns and epitope specificities of anti-Cryptococcus neofor-mans monoclonal antibodies by enzyme-linked immunosorbent assay and dot enzyme assay. Infect Immun 1997; 65: 718–728.
  • Casadevall A, Mukherjee J, Devi SJ, Schneerson R, Robbins JB, Scharff MD. Antibodies elicited by a Cryptococcus neoformans-tetanus toxoid conjugate vaccine have the same specificity as those elicited in infection. J Infect Dis 1992; 165: 1086–1093.
  • Mukherjee J, Nussbaum G, Scharff MD, Casadevall A. Protective and nonprotective monoclonal antibodies to Crypto-coccus neoformans originating from one B cell. J Exp Med 1995; 181: 405–409.
  • Cleare W, Casadevall A. The different binding patterns of two immunoglobulin M monoclonal antibodies to Cryptococcus neoformans serotype A and D strains correlate with serotype classification and differences in functional assays. Clin Diagn Lab Immunol 1998; 5: 125–129.
  • Lendvai N, Casadevall A. Monoclonal antibody-mediated toxicity in Cryptococcus neoformans infection: mechanism and relationship to antibody isotype.J Infect Dis 1999; 180: 791–801.
  • Mukherjee J, Pirofski LA, Scharff MD, Casadevall A. Anti-body-mediated protection in mice with lethal intracerebral Cryptococcus neoformans infection. Proc Natl Acad Sci USA 1993; 90: 3636–3640.
  • Mukherjee J, Kozel TR, Casadevall A. Monoclonal antibodies reveal additional epitopes of serotype D Cryptococcus neofor-mans capsular glucuronoxylomannan that elicit protective antibodies. J Immunol 1998; 161: 3557–3568.
  • Spiropulu C, Eppard RA, Otteson E, Kozel TR. Antigenic variation within serotypes of Cryptococcus neoformans detected by monoclonal antibodies specific for the capsular polysacchar-ide. Infect Immun 1989; 57: 3240–3242.
  • Kozel TR, deJong BC, Grinsell MM, MacGill RS, Wall KK. Characterization of anticapsular monoclonal antibodies that regulate activation of the complement system by the Crypto-coccus neoformans capsule. Infect Immun 1998; 66: 1538–1546.
  • Eckert TF, Kozel TR. Production and characterization of monoclonal antibodies specific for Cryptococcus neoformans capsular polysaccharide. Infect Immun 1987; 55: 1895–1899.
  • Ikeda R, Nishimura S, Nishikawa A, Shinoda T. Production of agglutinating monoclonal antibody against antigen 8 specific for Cryptococcus neoformans serotype D. Clin Diagn Lab Immunol 1996; 3: 89–92.
  • Canfield PJ, Hemsley S. The roles of histology and immunohis-tology in the investigation of marsupial disease and normal lymphoid tissue. Develop Comp Immunol 2000; 24: 455–471.
  • Hemsley SW, Canfield PJ, Husband AJ. Immunohistological staining of lymphoid tissue in four Australian marsupial species using species cross-reactive antibodies. Immunol Cell Biol 1995; 73: 321–325.
  • Shadomy HJ, Wood-Helie S, Shadomy S, Dismukes WE, Chau RY. Biochemical serogrouping of clinical isolates of Crypto-coccus neoformans [published erratum appears in Diagn Microbiol Infect Dis 1987; 7: 159]. Diagn Microbiol Infect Dis 1987; 6: 131–138.
  • Ikeda R, Shinoda T, Fukazawa Y, Kaufman L. Antigenic characterization of Cryptococcus neoformans serotypes and its application to serotyping of clinical isolates. J Clin Microbiol 1982; 16: 22–29.
  • Kozel TR, MacGill RS, Wall KK. Bivalency is required for anticapsular monoclonal antibodies to optimally suppress activation of the alternative complement pathway by the Cryptococcus neoformans capsule. Infect Immun 1998; 66: 1547–1553.
  • Rinaldi MG, Drutz DJ, Howell A, Sande MA, Wofsy CB, Hadley WK. Serotypes of Cryptococcus neoformans in patients with AIDS [letter]. J Infect Dis 1986; 153: 642.
  • Malik R, McPetrie R, Wigney DI, Craig AJ, Love DN. A latex cryptococcal antigen agglutination test for diagnosis and monitoring of therapy for cryptococcosis. Aust Vet J 1996; 74: 358–364.
  • Malik R, Dill-Macky E, Martin P, Wigney DI, Muir DB, Love DN. Cryptococcosis in dogs: a retrospective study of 20 consecutive cases. J Med Vet Mycol 1995; 33: 291–297.
  • Malik R, Wigney DI, Muir DB, Gregory DJ, Love DN. Cryptococcosis in cats: clinical and mycological assessment of 29 cases and evaluation of treatment using orally administered fluconazole. J Med Vet Mycol 1992; 30: 133–144.
  • Goldman D, Lee SC, Casadevall A. Pathogenesis of pulmonary Cryptococcus neoformans infection in the rat. Infect Immun 1994; 62: 4755–4761.
  • Goldman DL, Casadevall A, Cho Y, Lee SC. Cryptococcus neoformans meningitis in the rat. Lab Invest 1996; 75: 759–770.
  • Lee SC, Casadevall A, Dickson DW. Immunohistochemical localization of capsular polysaccharide antigen in the central nervous system cells in cryptococcal meningoencephalitis. Am J Pathol 1996; 148: 1267–1274.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.